Pre-Exposure Prophylaxis (PrEP) Updates Newsletter
PrEP Newsletter Volume 4 Issue 3 (December 2024)
- Review: Available PrEP Options, Financial Assistance Programs, & EPIC tools
- DoxyPEP & EPIC PrEP Smartsets Update, CDPHE Provider Trainings January 2025
- Lenacapavir: the Next Long Acting Injectable for HIV PrEP
- Mpox updates: Clade1 enters the US, vaccinations
PrEP Newsletter Volume 4 Issue 2 (April 2024)
- Review: Available PrEP Options, Financial Assistance Programs, & EPIC tools
- CDC STI Awareness Week April 14-21
- CDPHE Updated Syphilis Screening Guidance for Colorado
- Doxy PEP: Patient/Provider Resource Guide from Denver Doxy PEP Steering Committee
- Provider Sexual Health Discussion Topics
PrEP Newsletter Volume 4 Issue 1 (September 2023)
- Review: Available PrEP Options, Financial Assistance Programs, & EPIC tools
- DoxyPEP: Review of the Data
- XDR Shigellosis: On the Rise in Colorado
- Mycoplasma genitalium: Testing & Treatment Updates
PrEP Newsletter Volume 3 Issue 2 (August 2022)
- Review: Available PrEP Options & Financial Assistance Programs
- Apretude: Implementation Guidance for Injectable PrEP
- Doxy-PEP as an STI Prevention Strategy
- Monkeypox Resources
- HIV & Health Equities: Latinos & PrEP
- Updated UCHealth EPIC tools for PrEP
PrEP Newsletter Volume 2 Issue 3 (August 2021)
- Summary of Prior PrEP Newsletters
- Update on HIV Incidence in Colorado
- STIs on the rise:
- Congenital Syphilis: on the Rise in Colorado
- Expedited Partner Therapy: updated CDC STI Treatment Guidelines
- New Guidelines & FDA Approvals Coming Soon
PrEP Newsletter Volume 2 Issue 1 (November 2020)
- Summary of Prior PrEP Newsletters
- Dating and Sex during the Coronavirus Pandemic: Advice for Patients
- Racial and Ethnic Disparities in HIV Incidence and PrEP Access
- Pharmacist's Corner: Generic for PrEP, Insurance Coverage Updates